MedPath

Study of the effect of the exhale through the nose method by Inhaled corticosteroid and Long Acting Beta2 Agonist (ICS / LABA) combination drug in patients with asthma merger sinusitis

Not Applicable
Conditions
Asthma Sinusitis Eosinophilic sinusitis
Registration Number
JPRN-UMIN000021822
Lead Sponsor
Department of Otorhinolaryngology Showa University Koto Toyosu Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1)Those who in this study implementation period is scheduled to surgery for sinusitis 2)A person who has a history that is considered to have an impact on the evaluation of the study (drug abuse, dependence, alcohol abuse, dependence, digestive, heart, liver, lung, eye, blood diseases, etc.) 3)person of corticosteroids, while taking cromolyn sodium (oral oral medicine, nasal drops is not allowed) 4)those who are taking anti-histamines 5)Those who are receiving immunotherapy, including desensitization therapy 6)pregnant women, breast-feeding women 7)current smokers, non smoking duration a person of less than one year 8)Those who can not properly enforce the respiratory function test 9)Other, who is determined to be ineligible as a subject of the present study than test doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath